- Home
- CRVO
CRVO
CervoMed Inc.
as 03-25-2025 12:32pm EST
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 95.4M | IPO Year: | N/A |
| Target Price: | $25.43 | AVG Volume (30 days): | 13.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.80 - $25.92 | Next Earning Date: | 03-17-2025 |
| Revenue: | $9,737,974 | Revenue Growth: | 36.29% |
| Revenue Growth (this year): | -44.67% | Revenue Growth (next year): | N/A |
Latest CervoMed Inc. News
CRVO Breaking Stock News: Dive into CRVO Ticker-Specific Updates for Smart Investing
GlobeNewswire
9 hours ago
CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™)
Insider Monkey
6 days ago
Is CervoMed Inc. (CRVO) Among the Best Short Squeeze Stocks to Buy According to Analysts?
Simply Wall St.
7 days ago
CervoMed Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Insider Monkey
7 days ago
CervoMed Inc. (CRVO): The Best Short-Term Stock to Buy Right Now
GlobeNewswire
8 days ago
CervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates
Insider Monkey
8 days ago
Why CervoMed Inc. (CRVO) Soared Last Week?
TipRanks
11 days ago
CervoMed upgraded to Buy at JonesResearch on more confidence in DLB program
Simply Wall St.
11 days ago
We Think CervoMed (NASDAQ:CRVO) Can Afford To Drive Business Growth
Compare CRVO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CRVO CervoMed Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.